Bernhard Keppler Metallhaltige Verbindungen in
Werbung
Bernhard Keppler Metallhaltige Verbindungen in der Krebstherapie 2005 GDCh-Kolloquium Giessen Bernhard K. Keppler Metal Coordination Compounds in Cancer Therapy 2005 Younger European Chemists's Conference in Brno SET for Europe, Brno 2005 invited speaker invited speaker Bernhard Keppler New Antitumor-Active Metal Complexes, Preclinical Development and Clinical Experience Gordon Research GRC , Oxford 06.2006 plenary Bernhard K. Keppler, Development of a new metal compound as antitumor drugs – From bench to bedside ASBIC3, Nanjing China, 10.2006 keynote Bernhard Keppler Entwicklung neuer tumorhemmender Metallkomplexe: von der Synthese bis zur Klinik Kolloquium der Chemischen Gesellschaft in Heidelberg, 17.10.2006 invited speaker Bernhard Keppler Metal Coordination Compounds in Cancer Therapy Future Perspectives workshop on Metal Based Drugs, Jerusalem, 15.04.2007 invited speaker Bernhard Keppler Antitumor Active Metal Compounds –Sstrategies to Overcome Resistance”. Forschergruppe "Biologische Funktion von Organometallverbindungen" Berlin, 30.05.2007 invited speaker Bernhard Keppler NOVEL STRATEGIES TO DEVELOP NEW ANTITUMOR-ACTIVE METAL COMPOUNDS FIGIPAS 07, Wien, 5.07.2007 plenary Bernhard Keppler Development of New Antitumor Compounds – New Aspects 2nd ECCLSc, Wrclaw , 5. 9.2007 invited speaker Bernhard Keppler Preclinical Status and Clinical Development of New Non-Platinum Antitumor Drugs Verona, X ISPCC (International Symposiumon Platinum Coordination Compounds in Cancer Chemotherapy) 2.12.2007 plenary Bernhard Keppler The Development of Anticancer Active Coordination Compounds Chemistry and Cancer Meeting, University College Dublin, 15.Febr. 2008 invited speaker Bernhard Keppler Bioanorganische Entwicklung neuer Chemotherapeutika Arzneimittelforums der klinischen Pharmakologie, MUW Wien, Mai 2008 invited speaker Bernhard Keppler Beyond Platinum: Investigational Metallodrugs for Cancer Therapy Eurobic, Wrclaw, September 2008 keynote Bernhard Keppler Development of New Anticancer Metal Complexes - from Bench to Bedside Universität Siena , Juni 2008 invited speaker Bernhard Keppler Anticancer-Active Coordination Compounds - New Strategies Seminar ETH Zürich, Mai 2008 invited speaker Bernhard Keppler Tumor Therapy Based on Inorganic Compounds COST D39, Universität Leiden, Nov 2008 invited speaker Bernhard Keppler Expanding the metal-based armamentarium for cancer therapy COST Meeting, Irbid /Jordanien, Organometallic Complexes Containing Sulfur or Selenium Ligands, Oktober 2008 invited speaker Bernhard Keppler Von der Koordinationschemie zur Entwicklung neuer Krebstherapeutika COST D29 WG Meeting /Universität Jena, 9. Juli 2009 invited speaker Bernhard Keppler Tumor-inhibiting Metal Compounds from Bench to Bedside Nawi Tag Graz, 26. Juni 2009 invited speaker Bernhard Keppler Die Rolle der Koordinationschemie in der modernen Medizin am Beispiel neuer Krebstherapeutika Universität München , 9.Juli 2009 Wiberg Vorlesung Bernhard Keppler „Neue koordinationschemische Strategien zur Entwicklung von Tumortherapeutika GÖCH Kolloquium Universität Linz , 1. 06. 2010 invited lecture Bernhard Keppler „Entwicklung neuer antitumoraler Metallkomplexe“ Jahrestagung 2010 der Deutschen Pharmazeutischen Gesellschaft, Braunschweig Deutschland, 5. 10. 2010 plenary Bernhard Keppler “Recent Developments in Investigational Metal-Based Cancer Therapeutics” 10th European Biological Inorganic Chemistry Conference, Thessaloniki, Greece, 24. 06.2010 plenary Bernhard Keppler “Pre-clinical and clinical development of ruthenium and gallium compounds – an overview and update” Ce-M-M- Austrodrugs Research Center for Molecular Medicine of the Austrian Academy of Sciences 31.03.2011 invited lecture Bernhard Keppler “Combating Cancer with Metal Compounds - Approaches and Perspectives” First EuCheMS Inorganic Chemistry Conference (EICC-1) Manchester, England, 14.04.2011 invited lecture Bernhard Keppler “Technologietransfer an der Universität Wien” Inits-Veranstaltung (Universitäres Gründerservice GmbH) Konzept „Innovation goes Business“ 2011, 19. 05. 2011 Vortrag Univ Wien Bernhard Keppler “From coordination compounds to anticancer drugs” Metallomics 2011, Münster, Germany, 16. 06 2011 invited lecture Bernhard Keppler “Investigational Metal-Based Cancer Therapeutics − Recent Developments” 15th International Conference on Biological Inorganic Chemistry (ICBIC 15) Vancouver, Canada, 10. 08. 2011 Invited lecture Bernhard Keppler „Metalle in der Medizin. Von metallhaltigen Enzymen bis zu neuen Krebstherapeutika.“ Wiener Vorlesungen im Rahmen des Jahres der Chemie, 24. 11. 2011 Wiener Vorlesung Univ Wien Bernhard Keppler „Metallkomplexe in der Krebstherapie – Gibt es eine Zukunft für Ruthenium in der klinischen Therapie bösartiger Tumoren? „ Vortrag an Univ Gießen Gießen, Deutschland am 29. 05. 2013 invited speaker Bernhard Keppler “Recent Advances with Ruthenium Compounds in Cancer Treatment” 1st Russian Conference on Medicinal Chemistry" Moskau, Russland am 8. 09.2013 plenary Bernhard Keppler “Preclinical and Clinical Development of an Antitumor Ruthenium Compound (Update)” Austro Drugs Meeting, CeMM Forschungszentrum f Molekulare Medizin GmbH - d Österr. Akademie d Wissenschaften Wien, 07.03.2014 invited speaker Bernhard Keppler “Metal Complexes and Organometallic, Compounds in Anticancer Drug Development” XI Congress of the Interdivisional Group of Organometallic Chemistry (XI Co.G.I.C.O.) Mailand, Italien, 25. 06.2014 plenary Bernhard Keppler “Recent Advances in Bioinorganic Anticancer Drug Development” 12th European Biological Inorganic Chemistry Conference (EUROBIC 12) Zürich, 25.09.2014 invited speaker Bernhard Keppler “Development of Metal-based Anticancer Drugs in the Era of Targeted Therapies” 13th International Symposium on Applied Bioinorganic Chemistry ISABC13 NUI Galway 13. 07 2015 plenary Bernhard Keppler “Anticancer Metal Compounds in the Era of Targeted Therapies: Challenges and Approaches” GDCh Kolloquium Universität Bremen Bremen, 16. 11.2015 invited speaker